Chimera Biotec provides ultra sensitive GLP/GCP bioanalytical support for all phases of drug development and non-regulated rapid discovery phase research.

Building upon our proprietary Immuno-PCR technology, Imperacer®, our scientific team has gained extensive experience in the development and validation of ultra sensitive immunoassays.

Starting with our custom assay development or assay transfer on your preferred platform, take advantage of our strong scientific background and technical services - conducted under the strict quality regime.




Ultra sensitivity regardless of sample volume, matrix, and under GLP/GCP regulations.

For over 20 years, we have specialized in supporting drug development programs with highest demands on bioanalytical quality.

Our long standing know how in beyond ELISA sensitive immunoassays enables us to make the most out of any immunoassay platform.




Chimera Biotec has the longest track record in ultra sensitive ligand binding assays in the industry.

We provide premium services on more than our proprietary platforms, and state of the art solutions to tackle your most challenging study support.

In our GLP-certified bioanalytical lab, we use our outstanding expertise in beyond ELISA sensitivities in sub-pg/ml concentrations to fulfill sensitivity needs and regulatory demands.




The NRW Ministry for Economic Affairs, Innovation, Digitalisation and Energy is funding the joint project CovidDataNet.NRW with around 3.2 million…

Read more